Griselimycin
Griselimycin is a compound with antituberculosis activity that exhibits good in vitro and in vivo activity against sensitive and resistant Mycobacterium tuberculosis, and its cyclohexyl derivative has high transformative potential.
Product Specifications
CAS Number
26034-16-2
UNSPSC
12352209
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/griselimycin.html
Purity
98.3
Smiles
CC(N(C)[C@@H](C(C)C)C(N1[C@@H](C[C@H](C1)C)C(N([C@@H]2C(N[C@H](C(N3[C@](C[C@H](C3)C)([H])C(N[C@H](C(N([C@H](C(N4[C@](CCC4)([H])C(N([C@@H](C(NCC(O[C@@H]2C)=O)=O)CC(C)C)C)=O)=O)C(C)C)C)=O)CC(C)C)=O)=O)CC(C)C)=O)C)=O)=O)=O
Molecular Formula
C57H96N10O12
Molecular Weight
1113.43
References & Citations
[1]New Griselimycins for Treatment of Tuberculosis
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
